Alvotech (ALVO) News Today $8.65 -0.25 (-2.76%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Alvotech (NASDAQ:ALVO) Sees Strong Trading Volume - What's Next?1 hour ago | marketbeat.comAlvotech: A Fast-Expanding Biosimilar ConcernJuly 11, 2025 | seekingalpha.comAlvotech Appoints New CFO Amidst Continued GrowthJuly 10, 2025 | tipranks.comAlvotech names veteran Linda Jónsdóttir finance chiefJuly 10, 2025 | msn.comAlvotech Appoints Linda Jónsdóttir as Chief Financial OfficerJuly 10, 2025 | quiverquant.comQAlvotech Appoints Linda Jónsdóttir as Chief Financial OfficerJuly 10, 2025 | globenewswire.comAlvotech Appoints Linda Jónsdóttir as Chief Financial OfficerJuly 10, 2025 | globenewswire.comAlvotech acquires Ivers-Lee GroupJuly 9, 2025 | msn.comWhy Is Alvotech Stock Trading Higher On Wednesday?July 9, 2025 | benzinga.comAlvotech expands biosimilars capabilities with Ivers-Lee acquisitionJuly 9, 2025 | finance.yahoo.comAlvotech Acquires Ivers-Lee to Boost Biosimilar Packaging CapacityJuly 9, 2025 | tipranks.comAlvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in SwitzerlandJuly 9, 2025 | globenewswire.comAlvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in SwitzerlandJuly 9, 2025 | globenewswire.comAlvotech (NASDAQ:ALVO) Stock Price Down 2.3% - Time to Sell?July 9, 2025 | marketbeat.comAlvotech (ALVO) Announces a Commercialization Agreement With Advanz PharmaJuly 7, 2025 | finance.yahoo.comAlvotech (ALVO) Announces a Commercialization Agreement With Advanz PharmaJuly 6, 2025 | insidermonkey.comAlvotech S.A. Reports Increase in Own Shares to 6.73%, Exceeding 5% Voting Rights ThresholdJuly 3, 2025 | quiverquant.comQNotification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuersJuly 3, 2025 | globenewswire.comAlvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) - MorningstarJuly 2, 2025 | morningstar.comMGranting of Stock Options and Vesting of Restricted Share UnitsJuly 1, 2025 | globenewswire.comAlvotech and Advanz Pharma Forge European Biosimilar AgreementJuly 1, 2025 | tipranks.comAlvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)July 1, 2025 | globenewswire.comAlvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)July 1, 2025 | globenewswire.comAlvotech’s Lenders Lower Interest on Senior Secured Term Loan FacilityJune 26, 2025 | uk.finance.yahoo.comKashiv BioSciences reports positive results from trial of Xolair biosimilarJune 26, 2025 | msn.comAlvotech, Kashiv, Advanz announce study of AVT23 met primary endpointJune 26, 2025 | finance.yahoo.comAlvotech Secures Interest Rate Reduction on Senior Secured Term Loan Facility, Projected Savings of $8.2 MillionJune 26, 2025 | quiverquant.comQAlvotech's Lenders Lower Interest on Senior Secured Term Loan FacilityJune 26, 2025 | globenewswire.comAlvotech's Lenders Lower Interest on Senior Secured Term Loan FacilityJune 26, 2025 | globenewswire.comAlvotech (ALVO) Announces Approval of All Resolutions at 2025 AGM | ALVO stock newsJune 25, 2025 | gurufocus.comAlvotech (ALVO): A Bull Case TheoryJune 25, 2025 | finance.yahoo.comMain Results of 2025 Annual and Extraordinary General MeetingJune 25, 2025 | globenewswire.comMain Results of 2025 Annual and Extraordinary General MeetingJune 25, 2025 | globenewswire.comAlvotech reports positive results in study for Xolair biosimilarJune 25, 2025 | seekingalpha.comPositive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)June 25, 2025 | globenewswire.comPositive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)June 25, 2025 | globenewswire.comAlvotech (ALVO): A Bull Case TheoryJune 24, 2025 | insidermonkey.comBayer’s Eylea market grip set to slip as Alvotech biosimilar closes inJune 23, 2025 | finance.yahoo.comEuropean Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)June 23, 2025 | finance.yahoo.comEuropean Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept)June 23, 2025 | globenewswire.comEuropean Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept)June 23, 2025 | globenewswire.comAlvotech (NASDAQ:ALVO) Trading Down 3.3% - Should You Sell?June 16, 2025 | marketbeat.comAlvotech (NASDAQ:ALVO) Sees Significant Growth in Short InterestJune 15, 2025 | marketbeat.comAlvotech Completes Private Placement to Boost Shareholder BaseJune 12, 2025 | tipranks.comMillennium Management LLC Sells 107,172 Shares of Alvotech (NASDAQ:ALVO)June 12, 2025 | marketbeat.comAlvotech’s Private Placement Completed with Delivery of SDRs and Shares to InvestorsJune 11, 2025 | finance.yahoo.comAlvotech completes private placement with 40 institutional investorsJune 11, 2025 | investing.comAlvotech's Private Placement Completed with Delivery of SDRs and Shares to InvestorsJune 11, 2025 | globenewswire.comAlvotech's Private Placement Completed with Delivery of SDRs and Shares to InvestorsJune 11, 2025 | globenewswire.comAlvotech Partners with Dr. Reddy’s for Keytruda Biosimilar DevelopmentJune 11, 2025 | tipranks.com Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address ALVO Media Mentions By Week ALVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVO News Sentiment▼0.600.99▲Average Medical News Sentiment ALVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVO Articles This Week▼145▲ALVO Articles Average Week Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTRS News Today QGEN News Today ASND News Today BBIO News Today BPMC News Today VRNA News Today ROIV News Today ELAN News Today RVMD News Today LEGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVO) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.